Deletion and point mutations of PTHLH cause brachydactyly type E.

Institut für Medizinische Genetik, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
The American Journal of Human Genetics (Impact Factor: 11.2). 02/2010; 86(3):434-9. DOI: 10.1016/j.ajhg.2010.01.023
Source: PubMed

ABSTRACT Autosomal-dominant brachydactyly type E (BDE) is a congenital limb malformation characterized by small hands and feet predominantly as a result of shortened metacarpals and metatarsals. In a large pedigree with BDE, short stature, and learning disabilities, we detected a microdeletion of approximately 900 kb encompassing PTHLH, the gene coding for parathyroid hormone related protein (PTHRP). PTHRP is known to regulate the balance between chondrocyte proliferation and the onset of hypertrophic differentiation during endochondral bone development. Inactivation of Pthrp in mice results in short-limbed dwarfism because of premature differentiation of chondrocyte. On the basis of our initial finding, we tested further individuals with BDE and short stature for mutations in PTHLH. We identified two missense (L44P and L60P), a nonstop (X178WextX( *)54), and a nonsense (K120X) mutation. The missense mutation L60P was tested in chicken micromass culture with the replication-competent avian sarcoma leukosis virus retroviral expression system and was shown to result in a loss of function. Thus, loss-of-function mutations in PTHLH cause BDE with short stature.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes is one of the fastest growing diseases worldwide, with an immense economic and health burden attached. It is now well accepted that a deficiency of functional insulin-producing pancreatic beta-cells is the main cause for all forms of diabetes. Several approaches are being taken to increase functional beta-cell mass. These include differentiation of new beta-cells from stem cells or progenitor cells, transdifferentiation of beta-cells from other mature cell types, as well as finding ways to enhance the function, proliferation, survival, and regeneration of preexisting beta-cells. This article enumerates on the role of parathyroid hormone-related protein (PTHrP) and its mode of action on pancreatic beta-cell function, prolifera-tion, and survival in rodents as well as in human beta-cells. A further understanding of the mechanism of action of PTHrP and its role in the normal physiology and patho-physiology of the beta-cell will be important for its potential use in future as a therapeutic treatment for diabetes. Diabetes Diabetes is one of the fastest growing diseases worldwide, with a steep rise in its incidence expected in the next few decades [1, 2]. In the last two decades, among US adults aged 18 years or older, the annual number of new cases as well as diagnosed diabetes incidence almost tripled [3]. The estimated economic toll of diabetes is increasing nationally and internationally [4]. There is an urgent need to find ways to treat and/or cure diabetes, to alleviate the health and economic burden placed by this disease. Diabetes mellitus is a metabolic disease of insulin insufficiency leading to high blood sugar levels. There are many forms of diabetes, of which the two major types are type 1 diabetes (T1D) and type 2 diabetes (T2D). T1D is an autoimmune disease in which the body's immune system specifically attacks and destroys the pancreatic beta-cell, causing severe insulin deficiency and hyperglycemia [5, 6]. T2D, the more prevalent form of the disease, results from a combination of insulin resistance, inability of the body to properly sense and respond to insulin, and insufficient insulin production [7, 8]. It is now well accepted that all forms of diabetes ultimately develop due to an inadequate insulin supply, leading to increased blood glucose levels. If left untreated, chronic hyperglycemia causes tissue dam-age, producing the secondary complications of diabetes, which include diabetic neuropathy, nephropathy, retinop-athy, cardiovascular disease, and eventually increased mortality [3].
  • [Show abstract] [Hide abstract]
    ABSTRACT: The non-invasive prenatal detection of fetal microdeletions becomes increasingly challenging as the size of the mutation decreases, with current practical lower limits in the range of a few Mb. Our goals were to explore the lower limits of microdeletion size detection via NIPT using MINK and introduce/evaluate a novel statistical approach we recently developed called the GC Content Random Effect Model (GCREM). Maternal plasma was obtained from a pregnancy affected by a 4.2 Mb fetal microdeletion and three normal controls. Plasma DNA was subjected to capture of an 8 Mb sequence spanning the breakpoint region and sequenced. Data were analyzed with our published method, Minimally Invasive Karyotyping (MINK) and a new method called GCREM. The 8 Mb capture segment was divided into either 38 or 76 non-overlapping regions of 200Kb and 100Kb respectively. At 200Kb resolution, using GCREM (but not MINK) we obtained significant adjusted p values for all 20 regions overlapping the deleted sequence, and non-significant p values for all 18 reference regions. At 100Kb resolution, GCREM identified significant adjusted p values for all but one 100Kb region located inside the deleted region. Targeted sequencing and GCREM analysis may enable cost effective detection of fetal microdeletions and microduplications at high resolution. This article is protected by copyright. All rights reserved.
    Prenatal Diagnosis 01/2014; · 2.68 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Temtamy preaxial brachydactyly syndrome (TPBS) is an autosomal recessive rare disorder characterized by hyperphalangism of digits, facial dysmorphism, dental anomalies, sensorineural hearing loss, delayed motor and mental development, and growth retardation. Loss of function mutations have been recently reported in the CHSY1 gene to cause the TPBS. Here, we report a novel missense mutation (c.1897 G > A) in the CHSY1 gene in two TPBS patients from a consanguineous Pakistani family. The mutation predicted substitution of a highly conserved aspartate amino acid residue to asparagine at position 633 in the protein (D633N). Polyphen analysis supported the pathogenicity of D36N mutation. Our finding extends the body of recent evidence that supports the role of CHSY1 as a potential mediator of BMP signaling.
    European journal of medical genetics 11/2013; · 1.57 Impact Factor

Full-text (2 Sources)

Available from
May 17, 2014